Monday, October 26, 2020 10:15:28 AM
SALES GROWTH %: 989.81%
TPTW Partner Alliance: Thomas Scientific
Receives GOVT. COVID-19: $231.6 million contract
US companies dominate list of those landing largest COVID-19 contracts with the government.
#24. Thomas Scientific LLC
• Max. value of contracts won during COVID-19: $231.6 million
• Largest federal agency customer: Department of Homeland Security ($226.1 million)
• Total amount paid to date: $27.1 million (11.7% of potential total)
• Industry: Medical supplies
Thomas Scientific LLC is a medical supply company based in New Jersey. The COVID-19-related contracts the company currently has with the federal government could be worth over $231 million. The vast majority of that value is through contracts with the DHS, though the company also has a contract valued at over $5 million with the HHS. These contracts are for a range of supplies related to the COVID-19 pandemic, including 450,000 swabs and millions of viral transport media, or VTM, units.
https://www.google.com/amp/s/amp.usatoday.com/amp/111955066
*****No matter which way they manipulate this, TPTW has leveraged a partnership with a top tier, worldwide medical supplier, with Government Covid approved contracts currently valued at $231.6 million. Equates to TPTW having worldwide access through Thomas Scientific to leverage government bids and global medical deals for TPTW! Time will reveal the deals and I will continue to accumulate!
$$$TPTW$$$
Recent TPTW News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 06:06:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 07:44:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 05:49:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 07:18:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/05/2023 09:02:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 06/29/2023 04:15:04 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM